DAFNA Capital Management LLC
CIK 1389933
13F filing for Q2 2026・No. 3,790
- Holdings
- US$524.36M
- Quarter change
- +US$84.77M
- Entries
- 88
- Net bought (estimate)
- −US$32.69M
The quarter change is the holdings' value against the quarter before, price moves included — not what was bought or sold; each institution's page estimates that.
Net bought (estimate)
Each stock's change in shares at the quarter-end price, added up: a new position counts as bought, one sold out as sold, shares held long only. Splits are compared split-adjusted; corporate actions under a new CUSIP are not estimated. An estimate from the filings, not actual trades.
- New 17
- Sold out 11
- Cut 26
- Added 17
- Corporate actions 0
- Unchanged 28
Largest holdings
88 stocks worth US$524.36M, options and bonds left out.
| Stock | This quarter | Shares | Value | Weight |
|---|---|---|---|---|
| RVMDREVOLUTION MEDICINES INCCOM | Cut | 562,630 | US$105.37M | 20.09% |
| XBISPDR S&P BIOTECH ETFETF | Cut | 196,505 | US$31.1M | 5.93% |
| CMPSCOMPASS PATHWAYS PLCSPONSORED ADS | Cut | 2,011,952 | US$28.47M | 5.43% |
| STEREOTAXIS INCCOM NEW | Unchanged | 13,680,554 | US$23.53M | 4.49% |
| NEKTAR THERAPEUTICSCOM NEW | Added | 318,380 | US$22.23M | 4.24% |
| DNLIDENALI THERAPEUTICS INCCOM | Added | 739,014 | US$19.01M | 3.62% |
| IDEAYA BIOSCIENCES INCCOM | Added | 497,240 | US$18.53M | 3.53% |
| ATRCATRICURE INCCOM | Unchanged | 597,431 | US$16.72M | 3.19% |
| XENEXENON PHARMACEUTICALS INCCOM | Unchanged | 250,772 | US$15.14M | 2.89% |
| CYTOKINETICS INCCOM NEW | Cut | 171,998 | US$14.65M | 2.79% |
Sign in (free) to see its 50 largest holdings and its trades. Sign in
Filings
The quarter's original 13F filings (SEC).
- 13F-HRFiled August 14, 2026SEC ↗
13F covers long positions in US-listed securities only; the data is SEC's, filed within 45 days of the quarter's end.